| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/17/1997 | CN1159761A Vaccine compositions |
| 09/17/1997 | CN1159754A Improved pharmaceutical formulations containing ibuprofen and codeine |
| 09/17/1997 | CN1159351A Medicine magnetic response carrier and production method thereof |
| 09/17/1997 | CN1159350A Standard technological method of moderately substituted carboxymethyl starch copper used in dispersant sheet |
| 09/16/1997 | US5668177 Method of treating wrinkles using tartaric acid |
| 09/16/1997 | US5668170 Composition and method enhancing transdermal electrotransport agent delivery |
| 09/16/1997 | US5668117 Nervous system disorders using aromatic acid compounds |
| 09/16/1997 | US5668116 Anti-inflammatory compounds and compositions |
| 09/16/1997 | US5668111 Sustained-release preparation |
| 09/16/1997 | US5667808 Metal ion complex |
| 09/16/1997 | US5667805 Morphine therapy |
| 09/16/1997 | US5667803 Excipient in controlled release formulations, adjusting degree of substitution and compression force to control release properties |
| 09/16/1997 | US5667802 Antacid composition |
| 09/16/1997 | US5667801 Sustained release heterodisperse hydrogel systems for insoluble drugs |
| 09/16/1997 | US5667800 Lotions with lipids and emulsifiers |
| 09/16/1997 | US5667799 Method for treating headache pain with topical local anesthetic compositions |
| 09/16/1997 | US5667789 Emulsifier free, cosmetic and dermatological compositions, treatment of acne, aging |
| 09/16/1997 | US5667775 Phosphate-binding polymers for oral administration |
| 09/16/1997 | US5667767 Ethylene-vinyl alcohol copolymer; tantalum, tantalum oxide or barium sulfate as contrast agent |
| 09/16/1997 | US5667764 Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles |
| 09/16/1997 | US5667573 Erythritol, water soluble cellulose, drugs, foods |
| 09/16/1997 | US5667492 Use and composition of an anti-sexually transmitted diseases formulation |
| 09/16/1997 | CA2166483C New pharmaceutical formulation |
| 09/15/1997 | CA2199918A1 Absorbable copolymers and blends of 6,6-dialkyl-1,4-dioxepan-2-one and its cyclic dimer |
| 09/13/1997 | CA2199054A1 Preparation of water-soluble copolymers of at least one water-soluble n-vinyllactam and at least one hydrophobic comonomer |
| 09/12/1997 | WO1997033176A1 Graphitic nanotubes in luminescence assays |
| 09/12/1997 | WO1997032946A1 Substantially linear ethylene/alpha-olefin polymers as viscosity index improvers or gelling agents |
| 09/12/1997 | WO1997032891A2 Conjugate for modifying interactions between proteins |
| 09/12/1997 | WO1997032614A1 Microdispersions for coating surgical devices |
| 09/12/1997 | WO1997032609A2 Microencapsulated fluorinated gases for use as imaging agents |
| 09/12/1997 | WO1997032607A2 Activated linkers and methods for making and purifying the same |
| 09/12/1997 | WO1997032606A1 Pharmaceutical compositions containing buffered ortho ester polymers |
| 09/12/1997 | WO1997032602A1 DELIVERY SYSTEM USING mAb 3E10 AND MUTANTS AND/OR FUNCTIONAL FRAGMENTS THEREOF |
| 09/12/1997 | WO1997032596A1 Intercellular adhesion molecule powder formulation |
| 09/12/1997 | WO1997032584A1 Slow-release pharmaceutical formulations containing mizolastin |
| 09/12/1997 | WO1997032572A2 Materials and methods for enhancing cellular internalization |
| 09/12/1997 | WO1997028104A3 Buffer systems for use in stabilizing pharmaceutical preparations |
| 09/12/1997 | WO1997014785A3 Methods and compositions to improve germ cell and embryo survival and function |
| 09/12/1997 | CA2248233A1 Delivery system using mab 3e10 and mutants and/or functional fragments thereof |
| 09/12/1997 | CA2244894A1 Intercellular adhesion molecule powder formulation |
| 09/12/1997 | CA2198922A1 Compound thickened with a polysaccharide alkyl ether |
| 09/11/1997 | DE19608012A1 Stabilisation of super-saturated medicinal solutions by crystallisation inhibitors |
| 09/11/1997 | CA2199640A1 Finely dispersed carotenoid and retinoid suspensions and their preparation |
| 09/10/1997 | EP0794211A2 Blends containing absorbable polyoxaamides |
| 09/10/1997 | EP0793972A2 Adhesive percutaneous preparation |
| 09/10/1997 | EP0793967A2 Conjugated compounds of bile acids with thiotaurine and its N-alkyl derivatives |
| 09/10/1997 | EP0793966A1 Cyclosporin-containing topical pharmaceutical composition |
| 09/10/1997 | EP0793963A1 Percutaneously administrable preparation |
| 09/10/1997 | EP0793517A1 Composition and method for enhancing electrotransport agent delivery |
| 09/10/1997 | EP0793510A1 Methods for use of novel lyoprotectants and instant kit formulations for radiopharmaceuticals using the same |
| 09/10/1997 | EP0793507A2 Process for the preparation of a pharmacologically active chemical combination |
| 09/10/1997 | EP0793506A1 Cellular and serum protein anchors and conjugates |
| 09/10/1997 | EP0793504A1 Chimeric cytokines and uses thereof |
| 09/10/1997 | EP0793500A1 Pharmaceutical compositions comprising nitric oxide-releasing biopolymers |
| 09/10/1997 | EP0793497A1 Novel enediyne quinone imines and methods of preparation and use thereof |
| 09/10/1997 | EP0793485A1 Sustained-release drug delivery employing a powdered hydrocolloid gum obtainable from higher plants |
| 09/10/1997 | EP0793484A1 Adjuvant for a vaccine composition |
| 09/10/1997 | EP0689454B1 Vaccine compositions containing 3-o deacylated monophosphoryl lipid a |
| 09/10/1997 | EP0664701B1 Taste-masking compositions of ranitidine |
| 09/10/1997 | EP0644757B1 Pharmaceutical compositions containing nsaid and bile acids |
| 09/10/1997 | EP0617612B1 A process for the preparation of a solid dispersion |
| 09/10/1997 | CN1159162A Antithrombotic and non-hemorrhagic heparin-based compositions, method for their preparation and therapeutic applications |
| 09/10/1997 | CN1159158A Antibacterial oil-in-water emulsions |
| 09/10/1997 | CN1035801C Microgranular preparation useful in delivery of biologically active materials to intestinal regious of animals |
| 09/09/1997 | US5665864 Antibodies to a human integrin alpha/beta heterodimeric protein |
| 09/09/1997 | US5665782 Hydrolyzed gelatin as a flavor enhancer in a chewable table |
| 09/09/1997 | US5665776 Mixing a pharmaceutically active first ingredient with a second ingredient |
| 09/09/1997 | US5665767 Crystalline cyclodextrin complexes of ranitidine hydrochloride, process for their preparation and pharmaceutical compositions containing the same |
| 09/09/1997 | US5665760 Lyophilized thioxanthenone antitumor agents |
| 09/09/1997 | US5665711 Antitumor composition for oral administration |
| 09/09/1997 | US5665702 Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides |
| 09/09/1997 | US5665700 Pharmaceutical formulations |
| 09/09/1997 | US5665553 Methods for determining and modulating cellular redox potential and genotoxic states |
| 09/09/1997 | US5665539 Immuno-polymerase chain reaction system for antigen detection |
| 09/09/1997 | US5665428 Preparation of peptide containing biodegradable microspheres by melt process |
| 09/09/1997 | US5665390 Sustituted 3,5-diene steroidal compounds |
| 09/09/1997 | US5665389 Insulin, vibrio cholera zonula occludens toxin |
| 09/09/1997 | US5665386 Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
| 09/09/1997 | US5665383 Methods for the preparation of immunostimulating agents for in vivo delivery |
| 09/09/1997 | US5665382 Methods for the preparation of pharmaceutically active agents for in vivo delivery |
| 09/09/1997 | US5665380 Lipid vesicle fusion as a method of transmitting a biologically active material to a cell |
| 09/09/1997 | US5665377 Administration system for estradiol |
| 09/09/1997 | US5665358 Antibody drug-conjugates |
| 09/09/1997 | US5665328 Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles |
| 09/05/1997 | CA2199079A1 Blends of absorbable polyoxaamides |
| 09/04/1997 | WO1997031938A1 Oligopeptides for drug delivery |
| 09/04/1997 | WO1997031709A1 Antimicrobial compositions |
| 09/04/1997 | WO1997031655A2 Modified cytokines for therapeutic use |
| 09/04/1997 | WO1997031643A1 LOW pH GERMICIDAL IODINE COMPOSITIONS HAVING ENHANCED STABILITY |
| 09/04/1997 | WO1997031639A1 TABLETS CONTAINING β-LACTAM ANTIBIOTIC AND PROCESS FOR PRODUCING THE SAME |
| 09/04/1997 | WO1997031625A1 Inhibition of selectin binding |
| 09/04/1997 | WO1997031621A1 Delivery system for localized administration of medicaments to the upper respiratory tract |
| 09/04/1997 | CA2247308A1 Modified cytokines for therapeutic use |
| 09/04/1997 | CA2247048A1 Oligopeptides for drug delivery |
| 09/03/1997 | EP0792889A2 Use of inulin derivatives |
| 09/03/1997 | EP0792648A2 Pharmaceutical composition containing hirudin and process for its preparation |
| 09/03/1997 | EP0792644A1 Aqueous eye drops containing apafant as principal agent |
| 09/03/1997 | EP0792366A1 Enzyme gene therapy catalysing prodrug extracellular conversion |
| 09/03/1997 | EP0792330A1 A chitosan polymer having a specific degree of acetylation |
| 09/03/1997 | EP0792288A1 Conjugates of bdnf and nt-3 with a water-soluble polymer |